Home NDC 59148-009 ABILIFY
Product NDC 59148-009
11-digit product format 591480009
Labeler code 59148
Product ID 59148-009_1b189d15-798d-4bed-a93d-a543ed7abd81
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ARIPIPRAZOLE
Dosage form TABLET
Route ORAL
Labeler Otsuka America Pharmaceutical, Inc.
Application NDA021436
Marketing category NDA
Marketing start 2002-11-15
Substance ARIPIPRAZOLE
Active strength 15 mg/1
Pharmacologic classes Atypical Antipsychotic [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021436-001 ABILIFY ARIPIPRAZOLE 10MG TABLET / ORAL AB RLD, RS 2002-11-15 N021436-002 ABILIFY ARIPIPRAZOLE 15MG TABLET / ORAL AB RLD 2002-11-15 N021436-003 ABILIFY ARIPIPRAZOLE 20MG TABLET / ORAL AB RLD 2002-11-15 N021436-004 ABILIFY ARIPIPRAZOLE 30MG TABLET / ORAL AB RLD 2002-11-15 N021436-005 ABILIFY ARIPIPRAZOLE 5MG TABLET / ORAL AB RLD 2002-11-15 N021436-006 ABILIFY ARIPIPRAZOLE 2MG TABLET / ORAL AB RLD 2002-11-15
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 6 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 12 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 7 · 258 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N021436-001 ABILIFY 10MG TABLET / ORAL AB RLD, RS 2002-11-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021436-002 ABILIFY 15MG TABLET / ORAL AB RLD 2002-11-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021436-003 ABILIFY 20MG TABLET / ORAL AB RLD 2002-11-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021436-004 ABILIFY 30MG TABLET / ORAL AB RLD 2002-11-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021436-005 ABILIFY 5MG TABLET / ORAL AB RLD 2002-11-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021436-006 ABILIFY 2MG TABLET / ORAL AB RLD 2002-11-15 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021436-001 ABILIFY 10MG TABLET / ORAL AB RLD, RS 2002-11-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021436-002 ABILIFY 15MG TABLET / ORAL AB RLD 2002-11-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021436-003 ABILIFY 20MG TABLET / ORAL AB RLD 2002-11-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021436-004 ABILIFY 30MG TABLET / ORAL AB RLD 2002-11-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021436-005 ABILIFY 5MG TABLET / ORAL AB RLD 2002-11-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021436-006 ABILIFY 2MG TABLET / ORAL AB RLD 2002-11-15 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021436-001 ABILIFY 10MG TABLET / ORAL AB RLD, RS 2002-11-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021436-002 ABILIFY 15MG TABLET / ORAL AB RLD 2002-11-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021436-003 ABILIFY 20MG TABLET / ORAL AB RLD 2002-11-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021436-004 ABILIFY 30MG TABLET / ORAL AB RLD 2002-11-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021436-005 ABILIFY 5MG TABLET / ORAL AB RLD 2002-11-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021436-006 ABILIFY 2MG TABLET / ORAL AB RLD 2002-11-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021436-001 ABILIFY 10MG TABLET / ORAL AB RLD, RS 2002-11-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021436-002 ABILIFY 15MG TABLET / ORAL AB RLD 2002-11-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021436-003 ABILIFY 20MG TABLET / ORAL AB RLD 2002-11-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021436-004 ABILIFY 30MG TABLET / ORAL AB RLD 2002-11-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021436-005 ABILIFY 5MG TABLET / ORAL AB RLD 2002-11-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021436-006 ABILIFY 2MG TABLET / ORAL AB RLD 2002-11-15 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021436-001 ABILIFY 10MG TABLET / ORAL AB RLD, RS 2002-11-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021436-002 ABILIFY 15MG TABLET / ORAL AB RLD 2002-11-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021436-003 ABILIFY 20MG TABLET / ORAL AB RLD 2002-11-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021436-004 ABILIFY 30MG TABLET / ORAL AB RLD 2002-11-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021436-005 ABILIFY 5MG TABLET / ORAL AB RLD 2002-11-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021436-006 ABILIFY 2MG TABLET / ORAL AB RLD 2002-11-15 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021436-001 ABILIFY 10MG TABLET / ORAL AB RLD, RS 2002-11-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021436-002 ABILIFY 15MG TABLET / ORAL AB RLD 2002-11-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021436-003 ABILIFY 20MG TABLET / ORAL AB RLD 2002-11-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021436-004 ABILIFY 30MG TABLET / ORAL AB RLD 2002-11-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021436-005 ABILIFY 5MG TABLET / ORAL AB RLD 2002-11-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021436-006 ABILIFY 2MG TABLET / ORAL AB RLD 2002-11-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021436-001 ABILIFY 10MG TABLET / ORAL AB RLD, RS 2002-11-15 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021436-002 ABILIFY 15MG TABLET / ORAL AB RLD 2002-11-15 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021436-003 ABILIFY 20MG TABLET / ORAL AB RLD 2002-11-15 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021436-004 ABILIFY 30MG TABLET / ORAL AB RLD 2002-11-15 b8a1b40f171c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 7 · 258 observed states.
Observed Orange Book patent history# Patent history page 1 of 54 · 2,124 observed states.
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 54 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base ABILIFY
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ARIPIPRAZOLE 15 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 82VFR53I78 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 12 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 349490 Internal RxNorm lookup 349545 Internal RxNorm lookup 349547 Internal RxNorm lookup 349553 Internal RxNorm lookup 352307 Internal RxNorm lookup 352308 Internal RxNorm lookup 352309 Internal RxNorm lookup 352310 Internal RxNorm lookup 402131 Internal RxNorm lookup 404602 Internal RxNorm lookup 602964 Internal RxNorm lookup 615172 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 59148-009-13 ABILIFY 30 in 1 BOTTLE, PLASTIC TABLET 30 73 59148-009-35 ABILIFY 100 in 1 BLISTER PACK TABLET 100 73 59148-009-95 ABILIFY 7 in 1 BLISTER PACK TABLET 7 73
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ARIPIPRAZOLE ACTIVE INGREDIENT 82VFR53I78 ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 ARIPIPRAZOLE ACTIVE MOIETY 82VFR53I78 ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 ACESULFAME POTASSIUM INACTIVE INGREDIENT 23OV73Q5G9 ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 ALUMINUM OXIDE INACTIVE INGREDIENT LMI26O6933 ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 ASPARTAME INACTIVE INGREDIENT Z0H242BBR1 ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 CALCIUM SILICATE INACTIVE INGREDIENT S4255P4G5M ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 FRUCTOSE INACTIVE INGREDIENT 6YSS42VSEV ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 LACTIC ACID, DL- INACTIVE INGREDIENT 3B8D35Y7S4 ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 METHYLPARABEN INACTIVE INGREDIENT A2I8C7HI9T ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 PHENYLALANINE INACTIVE INGREDIENT 47E5O17Y3R ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 PROPYLPARABEN INACTIVE INGREDIENT Z8IX2SC1OH ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 SUCROSE INACTIVE INGREDIENT C151H8M554 ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 SULFOBUTYLETHER .BETA.-CYCLODEXTRIN INACTIVE INGREDIENT 2PP9364507 ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 TARTARIC ACID INACTIVE INGREDIENT W4888I119H ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 WATER INACTIVE INGREDIENT 059QF0KO0R ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 XYLITOL INACTIVE INGREDIENT VCQ006KQ1E ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] 56 ARIPIPRAZOLE ACTIVE INGREDIENT 82VFR53I78 ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT] 2 ARIPIPRAZOLE ACTIVE INGREDIENT 82VFR53I78 ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS] 2 ARIPIPRAZOLE ACTIVE MOIETY 82VFR53I78 ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT] 2 ARIPIPRAZOLE ACTIVE MOIETY 82VFR53I78 ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS] 2 ALUMINUM OXIDE INACTIVE INGREDIENT LMI26O6933 ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT] 2 ALUMINUM OXIDE INACTIVE INGREDIENT LMI26O6933 ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT] 2 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS] 2 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT] 2 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS] 2 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT] 2 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT] 2 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS] 2 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS] 2 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS] 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT] 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 59148-009 ABILIFY (ARIPIPRAZOLE) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] 73 Current NDC, Legacy NDC, 3 package rows 20250201_c040bd1d-45b7-49f2-93ea-aed7220b30ac.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ABILIFY ARIPIPRAZOLE Otsuka America Pharmaceutical, Inc. c040bd1d-45b7-49f2-93ea-aed7220b30ac 2025-01-29 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 021436 application number: NDA021436 ndc (product): 59148-009
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 59148-009-13 59148000913 30 TABLET in 1 BOTTLE, PLASTIC (59148-009-13) 30 tablet 2002-11-15 0000-00-00 No No Current 59148-009-35 59148000935 100 TABLET in 1 BLISTER PACK (59148-009-35) 100 tablet 2002-11-15 0000-00-00 No No Current 59148-009-95 59148000995 7 TABLET in 1 BLISTER PACK (59148-009-95) 7 tablet 2002-11-15 0000-00-00 No No Current